Sewoon Medical Co

Sewoon Medical Co EBITDA per Share

The EBITDA per Share of Sewoon Medical Co (100700.KQ) as of Nov 3, 2026 is 293.38 KRW. In the previous year, EBITDA per Share was 282.03 KRW — a change of 4.02% (higher).

EBITDA per Share

293.38KRW

YoY

4.02%

Last updated:

EBITDA per Share of Sewoon Medical Co is 2025 293.38 KRW. EBITDA per Share of Sewoon Medical Co was 2024 282.03 KRW. It decreases by 4.02% higher compared to the previous year.

The Sewoon Medical Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
424.94 KRW
Jan 1, 2019
401.70 KRW
Jan 1, 2020
342.45 KRW
Jan 1, 2021
373.28 KRW
Jan 1, 2022
299.81 KRW
Jan 1, 2023
410.23 KRW
Jan 1, 2024
282.03 KRW
Jan 1, 2025
293.38 KRW
The Sewoon Medical Co EBITDA per Share history
YEAREBITDA per ShareYoY
293.38KRW+4.02%
282.03KRW-31.25%
410.23KRW+36.83%
299.81KRW-19.68%
373.28KRW+9.00%
342.45KRW-14.75%
401.70KRW-5.47%
424.94KRW+35.91%
312.65KRW+17.05%
267.12KRW+17.45%
227.43KRW-8.06%
247.36KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sewoon Medical Co Stock analysis

What does Sewoon Medical Co do? Sewoon Medical Co Ltd manufactures pharmaceutical goods other than medicaments, focusing on medical devices. The company's product portfolio includes wound drainage systems branded as BAROVAC, urinary catheters and tubes such as silicon foley balloon catheters, latex foley balloon catheters, urinary self-catheters, and PVC nelaton catheters. Additionally, they produce drainage catheters and tubes like external ventricular drainage systems, gastric lavage systems, and silicone thoracic catheters. Their offerings also cover tracheal tubes including silicone endotracheal tubes and teflon tracheostomy tubes, alongside infusion devices such as central venous catheter kits and silicone gastric duodenal levin tubes. The company targets healthcare providers and medical institutions that require disposable medical devices for patient care. Products like urinary catheters, drainage systems, and tracheal tubes are essential in hospitals and clinics for procedures ranging from wound management to respiratory support. Sewoon Medical's focus on specific categories such as foley balloon catheters and thoracic catheters ensures they serve niche segments within the broader medical device market. Sewoon Medical Co Ltd generates revenue through the sale of its medical device products to hospitals, clinics, and healthcare facilities. The firm's portfolio emphasizes disposable items, which are regularly purchased by medical institutions for routine patient care and surgical procedures. By specializing in categories like urinary self-catheters and PVC nelaton catheters, the company caters to consistent demand within the healthcare sector. Sewoon Medical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sewoon Medical Co stock

EBITDA per Share of Sewoon Medical Co is 293.38 KRW in 2025.

EBITDA per Share of Sewoon Medical Co changed from 282.03 KRW to 293.38 KRW, representing a 4.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sewoon Medical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Sewoon Medical Co

All Key Metrics — Sewoon Medical Co